The record
| Class | bioregulator |
|---|---|
| Also known as | Ala-His-Lys, L-alanyl-L-histidyl-L-lysine, AHK tripeptide |
| Chain length | 3 residues |
| Molecular weight | 354.41 Da |
| Half-life | - |
| Route | SC / oral (class) |
| Studied for | - |
| Research use | - |
| What has been shown | - |
| How it works | Copper-binding tripeptide; the free (non-copper) form. Studied for hair-follicle dermal papilla proliferation and antioxidant activity; forms AHK-Cu with copper (a separate substance). |
| Patent status | - |
| Regulatory status | - |
Blank = not established in the record. Nothing is estimated to fill a gap.
Where it is matched
- Oxidative Stress Resilience (affection, 42%)
- Acetaminophen toxicity (illness, 30%)
- Antioxidant supplementation (illness, 30%)
- Detoxification support (illness, 30%)
- Erythropoietic protoporphyria - FDA approved (illness, 30%)
- Polymorphous light eruption (illness, 30%)
- Skin lightening (illness, 30%)
- Solar urticaria (illness, 30%)
- Vitiligo (illness, 30%)